Tilmann Bur News Today : Breaking News, Live Updates & Top Stories | Vimarsana

PAION AG: Sale of the business operations -December 22, 2023 at 10:35 am EST

EQS-News: PAION AG / Key word: Miscellaneous PAION AG: Sale of the business operations 22.12.2023 / 16:33 CET/CEST The issuer is solely responsible for the content of.

United statesYichang humanwellTilmann burDeutschland gmbRalf pennerMark boddenberg eckert rechtsanwMark boddenbergHumanwell healthcare groupInvestor relations corporate communicationsAachen local courtFrankfurt stock exchangeHumanwell healthcare group coSpecialty pharma companyEckert rechtsanw

PAION AG: Sale of the business operations

EQS-News: PAION AG / Key word(s): MiscellaneousPAION AG: Sale of the business operations 22.12.2023 / 16:33 CET/CESTThe issuer is solely responsible for the content of this announcement.PAION AG: Sale of the business operations  Aachen (Germany), 22 December 2023 - The Specialty Pharma Company PAION AG (ISIN DE.

United statesMark boddenberg eckert rechtsanwMark boddenbergTilmann burYichang humanwellDeutschland gmbRalf pennerFrankfurt stock exchangeHumanwell healthcare groupInvestor relations corporate communicationsSpecialty pharma companyHumanwell healthcare group coAachen local courtDistribution servicesEckert rechtsanwCorporate news

PAION AG to issue approximately 4 8 million shares at EUR 1 90 per share in capital increase with subscription rights

EQS-News: PAION AG / Key word: Capital Increase PAION AG to issue approximately 4.8 million shares at EUR 1.90 per share in capital increase with subscription rights.

South koreaUnited kingdomUnited statesSebastian wernerYichang humanwellRalf pennerTilmann burHumanwell healthcare groupFrankfurt stock exchangeEuropean investment bankInvestor relations corporate communicationsHumanwell healthcare group coManagement boardPrime standardSupervisory boardFederal gazette

EQS-News: PAION AG announces fully underwritten rights issue with target gross proceeds of EUR 10 million

EQS-News: PAION AG / Key word(s): Capital Increase PAION AG announces fully underwritten rights issue with target g.

United kingdomSouth koreaUnited statesTilmann burRalf pennerGerman federal financial supervisory authority bafinHumanwell healthcare groupInvestor relations corporate communicationsFrankfurt stock exchangeFrankfurt stock exchange prime standardManagement boardPrime standardSupervisory boardGerman federal financial supervisory authorityGerman federal gazetteCorporate communications

EQS-News: PAION ANNOUNCES SUBMISSION OF NEW DRUG APPLICATION FOR REMIMAZOLAM BY ITS LICENSEE MUNDIPHARMA IN JAPAN

EQS-News: PAION ANNOUNCES SUBMISSION OF NEW DRUG APPLICATION FOR REMIMAZOLAM BY ITS LICENSEE MUNDIPHARMA IN JAPAN
finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

United kingdomSouth koreaRemimazolam aneremTilmann burRalf pennerFrankfurt stock exchangeInvestor relations corporate communicationsPrime standardJapanese tradeIntravenous injection